Results 51 to 60 of about 26,008 (188)

Acidente vascular cerebral crônico: reabilitação [PDF]

, 2012
This study revised articles from the MEDLINE (PubMed) databases and other research sources, with no time limit. To do so, the search strategy adopted was based on (P.I.C.O.) structured questions (from the initials "Patient"; "Intervention"; "Control" and
Denise Rodrigues Tsukimoto, Denise Vianna Machado Ayres, Fabiola Olea Albieri, Linamara Rizzo Battistella, Mariana Vita Milazzotto, Marta Imamura, Munique Dias de Almeida, null null, Sissi Farrardo da Cruz, Thaís Tavares Terranova   +9 more
core   +2 more sources

Stroke prevention in atrial fibrillation: A narrative review of current evidence and emerging strategies

European Journal of Clinical Investigation, EarlyView.
Effective stroke prevention in AF requires a comprehensive holistic approach incorporating appropriate risk stratification, guideline‐adherent anticoagulation and management of underlying cardiovascular conditions and other comorbidities. The ABC pathway, supported by characterisation using the 4S‐AF framework, provides a structured approach to ...
Amir Askarinejad, Deirdre A. Lane, Parham Sadeghipour, Majid Haghjoo, Gregory Y. H. Lip   +4 more
wiley   +1 more source

Association of inferior vena cava filter placement for venous thromboembolic disease and a contraindication to anticoagulation with 30-day mortality [PDF]

, 2018
Importance: Despite the absence of data from randomized clinical trials, professional societies recommend inferior vena cava (IVC) filters for patients with venous thromboembolic disease (VTE) and a contraindication to anticoagulation therapy.
Brown, David L, Novak, Eric, Saeed, Mohammed J, Turner, Tyson E   +3 more
core   +1 more source

Early-start antiplatelet therapy after operation in patients with spontaneous intracerebral hemorrhage and high risk of ischemic events (E-start): Protocol for a multi-centered, prospective, open-label, blinded endpoint randomized controlled trial

Frontiers in Aging Neuroscience, 2022
BackgroundFor severe spontaneous intracerebral hemorrhage (sSICH) patients with high risk of ischemic events, the incidence of postoperative major cardiovascular/cerebrovascular and peripheral vascular events (MACCPE) is notable.
Kaiwen Wang, Kaiwen Wang, Shaohua Mo, Shaohua Mo, Qingyuan Liu, Qingyuan Liu, Jun Pu, Xiaobin Huang, Dezhi Kang, Fixin Lin, Dewei Zou, Xinguo Sun, Jinrui Ren, Xianzeng Tong, Jiangan Li, Rustam Al-Shahi Salman, Rustam Al-Shahi Salman, Nuochuan Wang, Shuaiwei Guo, Shuaiwei Guo, Yang Liu, Yang Liu, Yanan Zhang, Xiong Li, Jun Wu, Jun Wu, Shuo Wang, Shuo Wang   +27 more
doaj   +1 more source

Nomogram for Deep Vein Thrombosis Prediction Post‐Endovascular Thrombectomy in Acute Ischemic Stroke: A Retrospective Multicenter Observational Study

Journal of Clinical Nursing, EarlyView.
ABSTRACT Background Deep vein thrombosis (DVT) is a frequent complication following endovascular thrombectomy (EVT) in patients with acute ischaemic stroke (AIS), potentially leading to fatal pulmonary embolism (PE). Identifying patients early at high risk for DVT is clinically important.
Li Han, Teng‐Wei Pan, Li‐Li Yang, Wei‐Yang Qian, Xiao‐Ping Xu, Feng Wang, Wei‐Zhen Wang, Yang Liu, Wei‐Ying Yang   +8 more
wiley   +1 more source

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. [PDF]

, 2017
BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be ...
Bernstein, Richard A., Dubiel, Robert, Eikelboom, John W., Glund, Stephan, Huisman, Menno V., Hylek, Elaine M., Kam, Chak-Wah, Kamphuisen, Pieter W., Kreuzer, Jörg, Levy, Jerrold H., Pollack, Charles V., Reilly, Paul A., Royle, Gordon, Sellke, Frank W., Stangier, Joachim, Steiner, Thorsten, van Ryn, Joanne, Verhamme, Peter, Wang, Bushi, Weitz, Jeffrey I., Young, Laura   +20 more
core   +1 more source

Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source : Design of the NAVIGATE ESUS randomized trial [PDF]

, 2016
Peer ...
Amarenco, Pierre,, Ameriso, Sebastian F.,, Arauz, Antonio,, Bereczki, Daniel,, Berkowitz, Scott D.,, Bornstein, Natan,, Brouns, Raf,, Bryer, Alan, Connolly, Stuart J.,, Cunha, Luis,, Czlonkowska, Anna,, Davalos, Antoni,, Eckstein, Jens,, Endres, Matthias,, Gagliardi, Rubens J.,, Hankey, Graeme J.,, Hart, Robert G.,, Kasner, Scott E.,, Kirsch, Bodo,, Lang, Wilfried, Lavados, Pablo,, Lindgren, Arne,, Lund University., Lund University., Lund University., Mikulik, Robert,, Muir, Keith W.,, Mundl, Hardi,, Ntaios, George,, Ozturk, Serefnur,, O’Donnell, Martin J.,, Pare, Guillaume,, Pater, Calin,, Peacock, Frank,, Peters, Gary,, Pogue, Janice,, Shamalov, Nikolay,, Sharma, Mukul,, Shoamanesh, Ashkan,, Tatlisumak, Turgut,, Themeles, Ellison,, Toni, Danilo,, Uchiyama, Shinichiro,, Veltkamp, Roland,, Wang, Yilong,, Weitz, Jeffrey, Yoon, Byung Woo,   +46 more
core   +2 more sources

A case of recurrent aneurysm resulting from dual antiplatelet plus anticoagulation after confirmed aneurysm closure following coil-assisted flow diversion

Radiology Case Reports, 2022
Dual antiplatelet therapy (DAPT) is a management cornerstone for intracranial aneurysms treated with flow diversion. However, combined dual antiplatelet plus anticoagulation (triple therapy) can be indicated in some patients with important associated ...
Thomas R Geisbush, MD, Benjamin Pulli, MD, Dylan N Wolman, MD, Arjun V Pendharkar, MD, Nicholas A Telischak, MD   +4 more
doaj  

Post‐Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Objectives The present study investigated the effects of thrombosis, hemorrhagic events, disease progression, and secondary malignancies on patient survival after the diagnosis of essential thrombocythemia (ET). Methods We analyzed data from 1152 patients enrolled in the JSH‐MPN‐18 study using time‐dependent Cox regression and multistate ...
Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I. Saito, Akiko Kada, Akiko M. Saito, Kazuya Shimoda, Yuka Sugimoto, Toshiro Kurokawa, Akihiro Tomita, Yoko Edahiro, Hitoshi Kiyoi, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu   +24 more
wiley   +1 more source

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms [PDF]

, 2018
We analyzed 597 patients with myeloproliferative neoplasms (MPN) who presented transient ischemic attacks (TIA, n = 270) or ischemic stroke (IS, n = 327). Treatment included aspirin, oral anticoagulants, and cytoreductive drugs.
Arellano-Rodrigo, Eduardo, Barbui, Tiziano, Beggiato, Eloise, Bellini, Marta, Bertozzi, Irene, Betti, Silvia, Bonifacio, Massimiliano, Cacciola, Emma, Cacciola, Rossella, Carli, Giuseppe, Carobbio, Alessandra, Cattaneo, Daniele, Cazzola, Mario, Censori, Bruno, Cervantes, Francisco, Cortelezzi, Agostino, De Stefano, Valerio, Di Lazzaro, Vincenzo, Elli, Elena Maria, Ellis, Martin H., Finazzi, Guido, Finazzi, Maria Chiara, Gaidano, Gianluca, Gomez, Montse, Griesshammer, Martin, Guglielmelli, Paola, Hernandez-Boluda, Juan-Carlos, Iurlo, Alessandra, Loscocco, Giuseppe Gaetano, Lunghi, Francesca, Miroslava, Palova, Musolino, Caterina, Palandri, Francesca, Randi, Maria Luigia, Rapezzi, Davide, Rossi, Elena, Rumi, Elisa, Sadjadian, Parvis, Scaffidi, Luigi, Tieghi, Alessia, Vannucchi, Alessandro M., Vianelli, Nicola   +41 more
core   +5 more sources